부산대학교 도서관

Westphalen CB; Boscolo Bielo L; Aftimos P; Beltran H; Benary M; Chakravarty D; Collienne M; Dienstmann R; El Helali A; Gainor J; Horak P; Le Tourneau C; Marchiò C; Massard C; Meric-Bernstam F; Pauli C; Pruneri G; Roitberg F; Russnes HEG; Solit DB; Starling N; Subbiah V; Tamborero D; Tarazona N; Turnbull C; van de Haar J; André F; Mateo J; Curigliano G

Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Universidad de Granada (UGR)
ANNALS OF ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

Kuzbari, Z; Bandlamudi, C; Loveday, C; Garrett, A; Mehine, M; George, A; Hanson, H; Snape, K; Kulkarni, A; Allen, S; Jezdic, S; Ferrandino, R; Westphalen, CB; Castro, E; Rodon, J; Mateo, J; Burghel, GJ; Berger, MF; Mandelker, D; Turnbull, C

Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Tregel E; Rieke DT; Bleckmann A; Westphalen CB; Pretzell I; Lange S; Quante M; Kloker LD

Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101627692 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2296-5262 (Electronic) Linking ISSN: 22965270 NLM ISO Abbreviation: Oncol Res Treat Subsets: MEDLINE

Dorman K; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany. klara.dorman@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. klara.dorman@med.uni-muenchen.de.; Breitenwieser K; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; Fischer L; Max Planck Institute of Psychiatry, Munich, Germany.; Zhang D; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Probst V; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; Weiss L; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; Heinrich K; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; Kunz WG; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.; Holch JW; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Gießen-Jung C; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; Haas M; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; Department of Hematology and Oncology, München Klinik Neuperlach, Munich, Germany.; Boeck S; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Department of Hematology and Oncology, München Klinik Neuperlach, Munich, Germany.; von Bergwelt-Baildon M; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Landfarth T; Institute for Medical Information Processing, Biometry and Epidemiology, Faculty of Medicine, LMU Munich, Munich, Germany.; Hornung R; Institute for Medical Information Processing, Biometry and Epidemiology, Faculty of Medicine, LMU Munich, Munich, Germany.; Munich Center for Machine Learning (MCML), Munich, Germany.; Casuscelli J; Department of Urology, University Hospital, LMU Munich, Munich, Germany.; Berger-Thürmel K; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; Heinemann V; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Westphalen CB; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Reischer A; Department of Medicine III and Comprehensive Cancer Center, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Stenzinger A; Center for Personalized Medicine (ZPM), Heidelberg, Germany. albrecht.stenzinger@med.uni-heidelberg.de.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. albrecht.stenzinger@med.uni-heidelberg.de.; Westphalen CB; Comprehensive Cancer Center and Department of Medicine III, Ludwig Maximilian University of Munich, Munich, Germany.; Budczies J; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Kazdal D; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Ploeger C; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Altbürger C; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Evert M; Institute of Pathology, University of Regensburg, Regensburg, Germany.; Malek N; Center for Personalized Medicine (ZPM), Tübingen, Germany.; Department for Internal Medicine 1, Tübingen University Hospital, Tübingen, Germany.; Schirmacher P; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Klauschen F; Institute of Pathology, Ludwig Maximilian University of Munich, Munich, Germany.; BIFOLD-Berlin Institute for the Foundations of Learning and Data, Berlin, Germany.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE; In Process

Haebe S; Department of Medicine III, LMU University Hospital, Munich, Germany.; Schuebbe G; Department of Medicine III, LMU University Hospital, Munich, Germany.; Jurmeister P; Department of Pathology, LMU University Hospital, Munich, Germany.; von Bergwelt-Baildon M; Department of Medicine III, LMU University Hospital, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Westphalen CB; Department of Medicine III, LMU University Hospital, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Comprehensive Cancer Center (CCC Munich LMU), LMU University Hospital, Munich, Germany.; Lauer UM; Department of Medicine VIII, University Hospital Tübingen, Tübingen, Germany.; Kunz WG; Department of Radiology, LMU University Hospital, Munich, Germany.; Subklewe M; Department of Medicine III, LMU University Hospital, Munich, Germany.; Weigert O; Department of Medicine III, LMU University Hospital, Munich, Germany. oliver.weigert@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. oliver.weigert@med.uni-muenchen.de.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Dorman K; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Auernhammer CJ; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Spitzweg C; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Schmidmaier R; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Endocrine Tumors (ZET), LMU University Hospital, LMU Munich, Munich, Germany.; Nölting S; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, USZ, UZH, Zurich, Switzerland.; Kroiss M; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Endocrine Tumors (ZET), LMU University Hospital, LMU Munich, Munich, Germany.; Reincke M; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Endocrine Tumors (ZET), LMU University Hospital, LMU Munich, Munich, Germany.; Schulz C; Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Angele M; Department of General, Visceral and Transplant Surgery, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Werner J; Department of General, Visceral and Transplant Surgery, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Schmid-Tannwald C; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Endocrine Tumors (ZET), LMU University Hospital, LMU Munich, Munich, Germany.; Rauch J; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Zacherl M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Knösel T; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Kumbrink J; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.; Jung A; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.; Klauschen F; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.; Tufman A; Department of Medicine V, LMU University Hospital, LMU Munich, Munich, Germany.; Zhang D; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Weiss L; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Boeck S; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Department of Hematology and Oncology, Munich Municipal Hospital Neuperlach, Munich, Germany.; von Bergwelt-Baildon M; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Heinemann V; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Westphalen CB; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Heinrich K; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Kathrin.heinrich@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. Kathrin.heinrich@med.uni-muenchen.de.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany. Kathrin.heinrich@med.uni-muenchen.de.

Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE; In Process

Kramer KKM; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.; Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Westhofen T; Department of Urology, Ludwig-Maximilians-University of Munich, Munich, Germany.; Foglar M; Department of Urology, Ludwig-Maximilians-University of Munich, Munich, Germany.; Laser-Forschungslabor, LIFE Center, University Hospital, LMU Munich, Munich, Germany.; Ricke J; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.; Westphalen CB; Comprehensive Cancer Center and Department of Medicine III, Ludwig Maximilian University of Munich, Munich, Germany.; Unterrainer M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.; Kunz WG; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.; Mehrens D; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany. dirk.mehrens@med.uni-muenchen.de.

Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE

Witte D; Department of Hematology, Oncology and Palliative Care, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany. david.witte@ruhr-uni-bochum.de.; Pretzell I; West German Cancer Center, University Hospital Essen, Essen, Germany.; Reissig TM; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.; Stein A; Hematology-Oncology Practice Eppendorf, University Cancer Center Hamburg, Hamburg, Germany.; Velthaus JL; Hematology-Oncology Practice Eppendorf, University Cancer Center Hamburg, Hamburg, Germany.; Department of Oncology, Hematology and BMT with Section Pneumology, University of Hamburg, Hamburg, Germany.; Alig A; Department of Hematology, Oncology and Tumorimmunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Bohnenberger H; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.; Knödler M; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Kurreck A; Department of Hematology, Oncology and Tumorimmunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Sulzer S; Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center, Goettingen, Germany.; Beyer G; Medical Department II, LMU University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; Dorman K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Fröhlich T; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Hegenberg S; Department of Hematology, Oncology and Palliative Care, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.; Lugnier C; Department of Hematology, Oncology and Palliative Care, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.; Saborowski A; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.; Vogel A; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.; Lange S; TUM School of Medicine and Health, Department of Clinical Medicine, Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, Munich, Germany.; Reichert M; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; TUM School of Medicine and Health, Department of Clinical Medicine, Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, Munich, Germany.; Flade F; Hematology Practice Probstheida, Strümpellstraße 42, Leipzig, Germany.; Klaas L; Department of Internal Medicine II, Faculty of Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Utpatel K; Institute of Pathology, University Regensburg, Regensburg, Germany.; Becker H; Department of Hematology, Oncology and Stem Cell Transplantation, Center for Personalized Medicine, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.; Bleckmann A; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.; Wethmar K; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.; Reinacher-Schick A; Department of Hematology, Oncology and Palliative Care, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.; Westphalen CB; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

Konnerth D; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany. dinah.konnerth@med.uni-muenchen.de.; Gaasch A; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Westphalen CB; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center (CCC Munich LMU), University Hospital, LMU Munich, Munich, Germany.; Heinrich K; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Niyazi M; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.; Eze C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Rogowski P; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Marschner S; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; Zinn A; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; Corradini S; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Schönecker S; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE

Mansour N; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Heinrich K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; Zhang D; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK partner site Munich), Heidelberg, Germany.; Winkelmann M; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Ingenerf M; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Gold L; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Klambauer K; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Rudelius M; Institute of Pathology, Ludwig-Maximilians-Universität Munich, Munich, Germany.; Klauschen F; Institute of Pathology, Ludwig-Maximilians-Universität Munich, Munich, Germany.; Bergwelt-Baildon MV; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK partner site Munich), Heidelberg, Germany.; Ricke J; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Heinemann V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; Westphalen CB; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; Kunz WG; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. wolfgang.kunz@med.lmu.de.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany. wolfgang.kunz@med.lmu.de.

Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330 (Electronic) Linking ISSN: 14707330 NLM ISO Abbreviation: Cancer Imaging Subsets: MEDLINE; PubMed not MEDLINE

Mansour N; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Heinrich K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; Zhang D; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK partner site Munich), Heidelberg, Germany.; Winkelmann M; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Ingenerf M; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Gold L; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Klambauer K; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Rudelius M; Institute of Pathology, Ludwig-Maximilians-Universität Munich, Munich, Germany.; Klauschen F; Institute of Pathology, Ludwig-Maximilians-Universität Munich, Munich, Germany.; von Bergwelt-Baildon M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK partner site Munich), Heidelberg, Germany.; Ricke J; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Heinemann V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; Westphalen CB; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; Kunz WG; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. wolfgang.kunz@med.lmu.de.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany. wolfgang.kunz@med.lmu.de.

Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330 (Electronic) Linking ISSN: 14707330 NLM ISO Abbreviation: Cancer Imaging Subsets: MEDLINE

Lange S; Department of Internal Medicine II, Klinikum Rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, Munich, Bavaria, Germany.; Institute of Molecular Oncology and Functional Genomics, TUM School of Medicine and Health, Technische Universität München, Munich, Germany.; Lisiecki H; Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, Munich, Bavaria, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Würrtemberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany.; Heining C; Department for Translational Medical Oncology, National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ), Dresden, Saxony, Germany.; German Cancer Consortium (DKTK), Heidelberg, Baden-Württemberg, Germany.; Center for Personalized Oncology, National Center for Tumor Diseases Dresden (NCT) and University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden, Dresden, Germany.; Weiss L; Department of Medicine III, LMU Klinikum, Munich, Bavaria, Germany.; Westphalen CB; German Cancer Consortium (DKTK), Heidelberg, Baden-Württemberg, Germany.; Department of Medicine III, LMU Klinikum, Munich, Bavaria, Germany.; Comprehensive Cancer Center (CCC Munich LMU), LMU University Hospital Munich, Munich, Germany.; Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany.; Hübschmann D; German Cancer Consortium (DKTK), Heidelberg, Baden-Württemberg, Germany.; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; Jesinghaus M; Institute of Pathology, University Hospital Marburg, Marburg, Hesse, Germany.; Glimm H; Department for Translational Medical Oncology, National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ), Dresden, Saxony, Germany.; German Cancer Consortium (DKTK), Heidelberg, Baden-Württemberg, Germany.; Center for Personalized Oncology, National Center for Tumor Diseases Dresden (NCT) and University Hospital Carl Gustav Carus, Faculty of Medicine and Technische Universität Dresden, Dresden, Germany.; Translational Functional Cancer Genomics, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Würrtemberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Baden-Württemberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Pfarr N; Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, Munich, Bavaria, Germany.; Schlitter AM; Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, Munich, Bavaria, Germany melissa.schlitter@web.de.; German Cancer Consortium (DKTK), Heidelberg, Baden-Württemberg, Germany.

Publisher: BMJ Publishing Group Ltd & British Society of Gastroenterology Country of Publication: England NLM ID: 101660690 Publication Model: Electronic Cited Medium: Print ISSN: 2054-4774 (Print) Linking ISSN: 20544774 NLM ISO Abbreviation: BMJ Open Gastroenterol Subsets: MEDLINE

Lim, KHJ; Westphalen, CB; Berghoff, AS; Cardone, C; Connolly, EA; Guven, DC; Kfoury, M; Kocakavuk, E; Mando, P; Mariamidze, E

ESMO OPEN. 8(5):101625-101625

Dorman K; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Auernhammer CJ; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Spitzweg C; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Schmidmaier R; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Endocrine Tumors (ZET), LMU University Hospital, LMU Munich, Munich, Germany.; Nölting S; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, USZ, UZH, Zurich, Switzerland.; Kroiss M; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Endocrine Tumors (ZET), LMU University Hospital, LMU Munich, Munich, Germany.; Reincke M; Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Endocrine Tumors (ZET), LMU University Hospital, LMU Munich, Munich, Germany.; Schulz C; Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Angele M; Department of General, Visceral and Transplant Surgery, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Werner J; Department of General, Visceral and Transplant Surgery, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Schmid-Tannwald C; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Endocrine Tumors (ZET), LMU University Hospital, LMU Munich, Munich, Germany.; Rauch J; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Zacherl M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Knösel T; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Kumbrink J; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.; Jung A; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.; Klauschen F; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.; Tufman A; Department of Medicine V, LMU University Hospital, LMU Munich, Munich, Germany.; Zhang D; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Weiss L; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Boeck S; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Department of Hematology and Oncology, Munich Municipal Hospital Neuperlach, Munich, Germany.; von Bergwelt-Baildon M; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Heinemann V; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Westphalen CB; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany.; Heinrich K; Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Kathrin.heinrich@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. Kathrin.heinrich@med.uni-muenchen.de.; Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany. Kathrin.heinrich@med.uni-muenchen.de.

Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Möhrmann L; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, USA; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany. Electronic address: lino.moehrmann@nct-dresden.de.; Rostock L; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany.; Werner M; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Oleś M; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Arnold JS; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Paramasivam N; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Jöhrens K; Department of Pathology, University Hospital Carl Gustav Carus, Dresden, Germany.; Rupp L; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Schmitz M; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Richter D; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany.; Uhrig S; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Fröhlich M; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hutter B; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hüllein J; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Jahn A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Arlt M; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Möhrmann EE; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Hanf D; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Gieldon L; Institute of Medical Genetics, Carl von Ossietzky University, Oldenburg, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.; Heilig CE; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.; Teleanu MV; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.; Lipka DB; Section Translational Cancer Epigenomics, Department of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Beck K; Institute of Medical Genetics, Carl von Ossietzky University, Oldenburg, Germany.; Baude-Müller A; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany; Section Translational Cancer Epigenomics, Department of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Mock A; Institute of Pathology, Ludwig-Maximilians-Universität München (LMU), Munich, Germany.; Jelas I; Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Rieke DT; Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Wiesweg M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.; Brandts C; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Frankfurt, Germany; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.; Illert AL; Department of Internal Medicine I, Division of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg im Breisgau, Germany; Klinik und Poliklinik für Innere Medizin III, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.; Desuki A; University Cancer Center and Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany; TRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; DKTK, partner site Frankfurt/Mainz, a partnership between DKFZ and University Medical Center Mainz, Mainz, Germany.; Kindler T; University Cancer Center and Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany; TRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; DKTK, partner site Frankfurt/Mainz, a partnership between DKFZ and University Medical Center Mainz, Mainz, Germany.; Krackhardt AM; Klinik und Poliklinik für Innere Medizin III, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.; Westphalen CB; Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany.; Christopoulos P; Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, and NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center, member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Apostolidis L; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.; Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Allgäuer M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Neumann O; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Kerle IA; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Horak P; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.; Heining C; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Grosch H; Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, and NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center, member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Schröck E; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Hübschmann D; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany; Innovation and Service Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Fröhling S; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Glimm H; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Translational Functional Cancer Genomics, DKFZ Heidelberg, Heidelberg, Germany. Electronic address: hanno.glimm@nct-dresden.de.

Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE

Baird AM; Lung Cancer Europe (LuCE) Bern Switzerland.; From Testing to Targeted Treatments (FT3) Program Team, The Synergist Brussels Belgium.; Westphalen CB; Comprehensive Cancer Center Munich and Department of Medicine III University Hospital, LMU Munich Munich Germany.; Blum S; From Testing to Targeted Treatments (FT3) Program Team, The Synergist Brussels Belgium.; Roche Basel Switzerland.; Nafria B; From Testing to Targeted Treatments (FT3) Program Team, The Synergist Brussels Belgium.; Institut de Recerca Sant Joan de Déu Barcelona Spain.; Innovation and Research Department, Hospital Sant Joan de Déu Pg Barcelona Spain.; Knott T; From Testing to Targeted Treatments (FT3) Program Team, The Synergist Brussels Belgium.; Sarah Jennifer Knott (SJK) Foundation Dublin Republic of Ireland.; Sargeant I; Twist Medical Burlingame California USA.; Harnik H; From Testing to Targeted Treatments (FT3) Program Team, The Synergist Brussels Belgium.; The Synergist Brussels Belgium.; Brooke N; From Testing to Targeted Treatments (FT3) Program Team, The Synergist Brussels Belgium.; The Synergist Brussels Belgium.; Wicki N; From Testing to Targeted Treatments (FT3) Program Team, The Synergist Brussels Belgium.; The Synergist Brussels Belgium.; Wong-Rieger D; From Testing to Targeted Treatments (FT3) Program Team, The Synergist Brussels Belgium.; Canadian Organization for Rare Disorders Toronto Ontario Canada.

Publisher: John Wiley and Sons, Inc Country of Publication: United States NLM ID: 101728855 Publication Model: eCollection Cited Medium: Internet ISSN: 2398-8835 (Electronic) Linking ISSN: 23988835 NLM ISO Abbreviation: Health Sci Rep Subsets: PubMed not MEDLINE

Trama A; Department of Epidemiology and Data Science, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Licitra L; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Cavalieri S; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Bonfarnuzzo S; Department of Epidemiology and Data Science, Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Baili P; Department of Epidemiology and Data Science, Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Ciarfella A; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.; Parente P; Department of Otorhinolaryngologyand Head and Neck Surgery, La Corunna University Hospital, Corunna, Spain.; Almadori G; Department of Head-Neck Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo A. Gemelli, Rome, Italy.; Ansarin M; Head and Neck Program and Division of Otolaryngology Head &Nech Surgery, European Institue of Oncology, Milan, Italy.; Bacigalupo A; Radioterapia Oncologica, IRCCS-AOU Ospedale Policlinico San Martino - IST, Genoa, Italy.; Baumeister P; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, Ludwig-Maximilians University, Munich, Germany.; Baujat B; Otorhinolaryngology - Head and Neck surgery Department, APHP/Sorbonne Université, Hospital Tenon, Paris, France.; Bossi P; Medical Oncology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, ASST Ospedali Civili, Brescia, Italy.; Cavalera E; Department Oncological Radiotherapy, 'Vito Fazzi' Hospital, Lecce, Italy.; Cercato MC; Epidemiology and Cancer Registry Unit - IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Dieleman F; Department of Head and Neck Surgical Oncology, UMC Utrecht Centre of Expertise for Head and Neck Cancer, UMC Utrecht Cancer Centre, Utrecht, the Netherlands.; Fakhry N; Department of Oto-Rhino-Laryngology Head and Neck Surgery, La Conception University Hospital, AP-HM, Aix Marseille University, Marseilles, France.; Ferraresi V; Sarcoma and Rare Tumours Departmental Unit-IRCCS Regina Elena National Cancer Institute-Rome, Rome, Italy.; Gaino F; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.; Department of Otorhinolaryngology - Head and Neck Surgery, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.; Galizia D; Istituto di Candiolo, FPO - IRCCS, Candiolo (TO), Italy.; Halamkova J; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Department of Comprehensive Cancer Care, Masaryk University, Brno, Czech Republic.; Halme E; Department of Otorhinolaryngology - Head and Neck Surgery, Tampere University Hospital, Tampere, Finland.; Hardillo J; Department of otorhinolaryngology - Head and neck surgery, Erasmus University Medical Centre Rotterdam, Rotterdam, the Netherlands.; Hofauer B; Comprehensive Cancer Centre Munich, Munich, Germany.; Kinloch E; Salivary Gland Cancer UK, International House, London, United Kingdom.; Livi L; Department of Oncological Radiotherapy, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.; Locati LD; Department of Medical Oncology of Head and Neck Tumours, ICS Maugeri SpA SB - IRCCS, Pavia, Italy.; Mattheis S; Ear, Nose and Throat Clinic, Essen Univerity Hospital, Essen, Germany.; Mercante G; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.; Department of Otorhinolaryngology - Head and Neck Surgery, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.; Mirabile A; Department of Medical Oncology, IRCCS San Raffaele, Milan, Italy.; Molteni G; Otolaryngology Head and Neck Surgery Department, University Hospital, Verona, Italy.; Orlandi E; Clinical Department, Radiotherapy Unit, National Centre for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.; Persio R; Italian Association of Laryngectomees, Milan, Italy.; Sciallero S; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Smeele L; Department of Head and Neck surgery, Surgical Oncology Division, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Tagliabue M; Department of Otolaryngology Head & Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.; Valentini V; Unit of Surgical Oncology, Maxillo Facial Reconstruction, Policlinico Umberto I, Rome, Italy.; Van Harpen C; Department Medical Oncology, Radboud University Medical Centre, HB Nijmegen (HP 455), Nijmegen, the Netherlands.; Westphalen CB; Comprehensive Cancer Centre Munich & Department of Medicine III, German Cancer Consortium (DKTK), Ludwig Maximilian University of Munich, Munich, Germany.; Botta L; Department of Epidemiology and Data Science, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Casolino R; Wolfson Wohl Cancer Research Center, School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Beer PA; Wolfson Wohl Cancer Research Center, School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Hull York Medical School, York, UK.; Chakravarty D; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Davis MB; Department of Surgery, Weill Cornell Medicine, New York City, New York, USA.; Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.; Mazzarella L; Laboratory of Translational Oncology and Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors IEO European Institute of Oncology, IRCCS, Milan, Italy.; Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori, IRCCS 'Fondazione G. Pascale', Naples, Italy.; Pauli C; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.; Subbiah V; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Turnbull C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; National Cancer Registration and Analysis Service, National Health Service (NHS) England, London, UK.; Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Westphalen CB; Department of Medicine III, Ludwig Maximilians University (LMU) Hospital Munich, Munich, Germany.; Comprehensive Cancer Center, LMU Hospital Munich, Munich, Germany.; German Cancer Consortium, LMU Hospital Munich, Munich, Germany.; Biankin AV; Wolfson Wohl Cancer Research Center, School of Cancer Sciences, University of Glasgow, Glasgow, UK.; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK.; South Western Sydney Clinical School, Liverpool, New South Wales, Australia.

Publisher: Wiley Country of Publication: United States NLM ID: 0370647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-4863 (Electronic) Linking ISSN: 00079235 NLM ISO Abbreviation: CA Cancer J Clin Subsets: MEDLINE

Weiss L; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.; Heinemann V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Fischer LE; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.; Gieseler F; Department of Hematology and Oncology, University Hospital Schleswig-Holstein-Campus Lübeck, Lübeck, Germany.; Hoehler T; Department of Medicine I, Prosper Hospital, Recklinghausen, Germany.; Mayerle J; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.; Quietzsch D; Department of Medical Oncology, Klinikum Chemnitz, Chemnitz, Germany.; Reinacher-Schick A; Department of Hematology and Oncology, St. Josef Hospital, Ruhr University, Bochum, Germany.; Schenk M; Department of Hematology and Oncology, Klinikum Barmherzige Brüder, Regensburg, Germany.; Seipelt G; Onkologie Main-Taunus, Bad Soden, Germany.; Siveke JT; West German Cancer Center, Bridge Institute of Experimental Tumor Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.; Stahl M; Department of Medical Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany.; Vehling-Kaiser U; MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany.; Waldschmidt DT; Department of Gastroenterology and Hepatology, University of Cologne, Cologne, Germany.; Dorman K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Zhang D; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Westphalen CB; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.; von Bergwelt-Baildon M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Boeck S; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Haas M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. michael.haas@med.uni-muenchen.de.; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany. michael.haas@med.uni-muenchen.de.

Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE